These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16845178)

  • 1. Nitric oxide, caveolae, and vascular pathology.
    Li XA; Everson W; Smart EJ
    Cardiovasc Toxicol; 2006; 6(1):1-13. PubMed ID: 16845178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy.
    Zhang Y; Janssens SP; Wingler K; Schmidt HH; Moens AL
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H634-46. PubMed ID: 21622818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding eNOS for pharmacological modulation of endothelial function: a translational view.
    Braam B; Verhaar MC
    Curr Pharm Des; 2007; 13(17):1727-40. PubMed ID: 17584103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial caveolar subcellular domain regulation of endothelial nitric oxide synthase.
    Ramadoss J; Pastore MB; Magness RR
    Clin Exp Pharmacol Physiol; 2013 Nov; 40(11):753-64. PubMed ID: 23745825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular localization of oxidants and redox modulation of endothelial nitric oxide synthase.
    Maron BA; Michel T
    Circ J; 2012; 76(11):2497-512. PubMed ID: 23075817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Penetrating Peptide-Mediated Caveolae-Dependent Activation of Lung Endothelial Nitric Oxide Synthase.
    Hutchinson TE; Hu H; Patel JM
    Protein Pept Lett; 2016; 23(2):169-75. PubMed ID: 26655728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae.
    Mineo C; Shaul PW
    Cardiovasc Res; 2006 Apr; 70(1):31-41. PubMed ID: 16540099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium-Derived Nitric Oxide as an Antiatherogenic Mechanism: Implications for Therapy.
    Sukhovershin RA; Yepuri G; Ghebremariam YT
    Methodist Debakey Cardiovasc J; 2015; 11(3):166-71. PubMed ID: 26634024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caveolae Depletion Contributes to Vasorelaxant Effects of Chenodeoxycholic Acid.
    Wang Z; Lv Q; Liu H; Wu Y; Bai Y; Cheng Y; Su Y; Cai Y; Yu J; Ma J; Bao J
    Cell Physiol Biochem; 2017; 42(3):1013-1024. PubMed ID: 28662517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
    Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
    J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting and translocation of endothelial nitric oxide synthase.
    Michel T
    Braz J Med Biol Res; 1999 Nov; 32(11):1361-6. PubMed ID: 10559837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae.
    Li Q; Zhang Q; Wang M; Liu F; Zhao S; Ma J; Luo N; Li N; Li Y; Xu G; Li J
    Arch Biochem Biophys; 2007 Oct; 466(2):250-9. PubMed ID: 17662956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae.
    Peterson TE; Poppa V; Ueba H; Wu A; Yan C; Berk BC
    Circ Res; 1999 Jul; 85(1):29-37. PubMed ID: 10400908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of eNOS in caveolae.
    Mineo C; Shaul PW
    Adv Exp Med Biol; 2012; 729():51-62. PubMed ID: 22411313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The eNOS signalosome and its link to endothelial dysfunction.
    Siragusa M; Fleming I
    Pflugers Arch; 2016 Jul; 468(7):1125-1137. PubMed ID: 27184745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
    Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
    Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
    Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O
    Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.
    Moens AL; Vrints CJ; Claeys MJ; Timmermans JP; Champion HC; Kass DA
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H1971-7. PubMed ID: 18375715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
    Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation.
    Mount PF; Kemp BE; Power DA
    J Mol Cell Cardiol; 2007 Feb; 42(2):271-9. PubMed ID: 16839566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.